StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Saturday morning. The firm issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Performance
NAVB stock remained flat at $0.00 during midday trading on Friday. The company had a trading volume of 6,481 shares, compared to its average volume of 5,483. The business’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.03. The company has a market capitalization of $100,084.00, a price-to-earnings ratio of -0.02 and a beta of 1.49. Navidea Biopharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.15.
About Navidea Biopharmaceuticals
Featured Stories
- Five stocks we like better than Navidea Biopharmaceuticals
- What is a Stock Market Index and How Do You Use Them?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- How to Use the MarketBeat Excel Dividend Calculator
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.